Parkside Financial Bank & Trust’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-145
Closed -$580 2721
2025
Q4
$580 Buy
145
+45
+45% +$250 ﹤0.01% 2544
2025
Q3
$846 Sell
100
-252
-72% -$2.44K ﹤0.01% 2356
2025
Q2
$3.96K Buy
352
+50
+17% +$459 ﹤0.01% 1792
2025
Q1
$2.86K Sell
302
-4,655
-94% -$47K ﹤0.01% 1784
2024
Q4
$55.8K Buy
4,957
+2,358
+91% +$41.4K 0.01% 764
2024
Q3
$73.5K Buy
+2,599
New +$67K 0.01% 641
2020
Q2
Sell
-3,602
Closed -$20K 1536
2020
Q1
$20K Sell
3,602
-139
-4% -$1.24K 0.01% 568
2019
Q4
$34K Buy
3,741
+122
+3% +$991 0.01% 508
2019
Q3
$26K Sell
3,619
-85
-2% -$610 0.01% 550
2019
Q2
$29K Buy
3,704
+154
+4% +$1.82K 0.01% 529
2019
Q1
$45K Sell
3,550
-78
-2% -$1.24K 0.02% 399
2018
Q4
$72K Buy
3,628
+1,327
+58% +$30.7K 0.03% 296
2018
Q3
$65K Hold
2,301
0.02% 315
2018
Q2
$48K Buy
2,301
+1,029
+81% +$19.5K 0.02% 362
2018
Q1
$18K Sell
1,272
-165
-11% -$2.36K 0.01% 594
2017
Q4
$18K Buy
1,437
+22
+2% +$310 0.01% 600
2017
Q3
$25K Sell
1,415
-9
-0.6% -$185 0.01% 479
2017
Q2
$36K Buy
+1,424
New +$34.2K 0.01% 402

Other funds holding EVH

Parkside Financial Bank & Trust's EVH Position: Q1 2026 in Review

Parkside Financial Bank & Trust sold out of Evolent Health (EVH) in Q1 2026, closing a stake of 145 shares — an estimated $580 sold.

Parkside Financial Bank & Trust first reported a position in EVH in Q2 2017 and held it in 18 quarters. The position peaked at $73.5K in Q3 2024. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Parkside Financial Bank & Trust reported no remaining Evolent Health position as of Q1 2026 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 145 Evolent Health shares in Q1 2026, an estimated $580.
  • Parkside Financial Bank & Trust first reported a position in Evolent Health in Q2 2017 and held it in 18 quarters.
  • Parkside Financial Bank & Trust's Evolent Health position peaked at $73.5K in Q3 2024.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.